Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Galan
  RBR-8h7q82		 RCTivermectinchloroquine and derivativesCOVID-19 severe or criticallysome concern
53/115 suggested
  • inconclusive 6 % decrease in deaths,deaths (time to event analysis only) (PE) with a moderate degree of certainty due to some concern in risk of bias
  • suggested 86 % decrease in mechanical ventilation with a moderate degree of certainty due to some concern in risk of bias
Galan
  RBR-8h7q82		 RCTivermectinhydroxychloroquineCOVID-19 severe or criticallysome concern
53/115 suggested
  • inconclusive 6 % decrease in deaths,deaths (time to event analysis only) (PE) with a moderate degree of certainty due to some concern in risk of bias
  • suggested 86 % decrease in mechanical ventilation with a moderate degree of certainty due to some concern in risk of bias
2 studies excluded by filtering options (0 RCT / 2 OBS)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons